Submitted by Anonymous (not verified) on 19 September 2025 - 14:45
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 5, Status: Authorised